Yukari Bando

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Combination Therapy

Metastatic Renal Cell Carcinoma

Tyrosine Kinase

Editorial Comment

Top Venues

International journal of urology : official journal of the Japanese Urological Association

Investigative and clinical urology

This page only lists publications with an associated author ORCID identifier.

Publications

Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Syuya Kandori, Kazutoshi Fujita, Kousuke Ueda, Hajime Tanaka, Ryotaro Tomida, Toshifumi Kurahashi, Yukari Bando, Naotaka Nishiyama, Takahiro Kimura, Shimpei Yamashita, Hiroshi Kitamura, Hideaki Miyake, null null
Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy. International journal of urology : official journal of the Japanese Urological Association (2024)
Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Syuya Kandori, Kazutoshi Fujita, Kousuke Ueda, Hajime Tanaka, Ryotaro Tomida, Toshifumi Kurahashi, Yukari Bando, Naotaka Nishiyama, Takahiro Kimura, Shimpei Yamashita, Hiroshi Kitamura, Hideaki Miyake, null null
Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Syuya Kandori, Kazutoshi Fujita, Kousuke Ueda, Hajime Tanaka, Ryotaro Tomida, Toshifumi Kurahashi, Yukari Bando, Naotaka Nishiyama, Takahiro Kimura, Shimpei Yamashita, Hiroshi Kitamura, Hideaki Miyake, null null
Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Kotaro Suzuki, Yasuyoshi Okamura, Yukari Bando, Takuto Hara, Keisuke Okada, Tomoaki Terakawa, Yoji Hyodo, Koji Chiba, Jun Teishima, Yuzo Nakano, Hideaki Miyake
Adrenalectomy for pheochromocytoma: Surgical outcomes and preoperative risk factors for hemodynamic instability. International journal of urology : official journal of the Japanese Urological Association (2024)
Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Syuya Kandori, Kazutoshi Fujita, Kousuke Ueda, Hajime Tanaka, Ryotaro Tomida, Toshifumi Kurahashi, Yukari Bando, Naotaka Nishiyama, Takahiro Kimura, Shimpei Yamashita, Hiroshi Kitamura, Hideaki Miyake, null null
Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Takuto Hara, Junya Furukawa, Yusuke Shiraishi, Yasuyoshi Okamura, Yukari Bando, Tomoaki Terakawa, Ken-Ichi Harada, Yuzo Nakano, Masato Fujisawa
Impact of cytoreductive nephrectomy prior to combination therapy of ipilimumab plus nivolumab in metastatic renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association (2023)
Takuto Hara, Junya Furukawa, Yasuyoshi Okamura, Yukari Bando, Tomoaki Terakawa, Ken-Ichi Harada, Satoru Takahashi, Yuzo Nakano, Masato Fujisawa
The poor antitumor effect of pembrolizumab in advanced upper urothelial carcinoma with renal parenchymal invasion. International journal of urology : official journal of the Japanese Urological Association (2023)
Ken-Ichi Harada, Ryo Sato, Yukari Bando, Asuka Sano, Yuto Matsushita, Keita Tamura, Tomoaki Terakawa, Junya Furukawa, Naohiro Fujimoto, Masato Fujisawa, Hideaki Miyake
Efficacy and safety of pembrolizumab and axitinib as first-line treatment for patients with advanced renal cell carcinoma: Real-world experience in Japan. International journal of urology : official journal of the Japanese Urological Association (2023)
Hideto Ueki, Takuto Hara, Yasuyoshi Okamura, Yukari Bando, Tomoaki Terakawa, Junya Furukawa, Ken-Ichi Harada, Yuzo Nakano, Masato Fujisawa
Association between sarcopenia based on psoas muscle index and the response to nivolumab in metastatic renal cell carcinoma: A retrospective study. Investigative and clinical urology 63 (4) (2022)
Yukari Bando, Nobuyuki Hinata, Tomoaki Terakawa, Junya Furukawa, Kenichi Harada, Yuzo Nakano, Masato Fujisawa
Diagnostic and therapeutic value of pelvic lymph node dissection in the fossa of Marcille in patients with clinically localized high-risk prostate cancer: Histopathological and molecular analyses. The Prostate 80 (4) (2020)